The latest quarterly R&D expense is $4.45 Million with a QoQ Growth of +10.92%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $4.45M.
$4.45M
$4.45 Million
Q2 FY2026 · 2026-06-30
+10.92%
vs. $4.01M prior quarter
22
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $4.45M | +10.92% | +35.21% |
| Q1 FY2026Period end 2026-03-31 | $4.01M | +1.74% | +11.22% |
| Q4 FY2025Period end 2025-12-31 | $3.95M | +5.75% | -4.31% |
| Q3 FY2025Period end 2025-09-30 | $3.73M | +13.30% | -3.98% |
| Q2 FY2025Period end 2025-06-30 | $3.29M | -8.76% | +76.98% |
| Q1 FY2025Period end 2025-03-31 | $3.61M | -12.47% | +103.19% |
| Q4 FY2024Period end 2024-12-31 | $4.12M | +6.13% | +253.87% |
| Q3 FY2024Period end 2024-09-30 | $3.89M | +108.82% | +194.97% |
| Q2 FY2024Period end 2024-06-30 | $1.86M | +4.75% | +54.96% |
| Q1 FY2024Period end 2024-03-31 | $1.78M | +52.44% | +29.31% |
| Q4 FY2023Period end 2023-12-31 | $1.17M | -11.54% | -52.93% |
| Q3 FY2023Period end 2023-09-30 | $1.32M | +9.71% | N/A |
| Q2 FY2023Period end 2023-06-30 | $1.20M | -12.59% | +570.67% |
| Q1 FY2023Period end 2023-03-31 | $1.37M | -44.51% | +646.81% |
| Q4 FY2022Period end 2022-12-31 | $2.48M | N/A | +903.99% |
| Q3 FY2022Period end 2022-09-30 | $116.62K | -34.87% | -46.21% |
| Q2 FY2022Period end 2022-06-30 | $179.05K | -2.67% | -25.33% |
| Q1 FY2022Period end 2022-03-31 | $183.96K | -25.41% | -0.94% |
| Q4 FY2021Period end 2021-12-31 | $246.61K | +13.75% | N/A |
| Q3 FY2021Period end 2021-09-30 | $216.80K | -9.59% | N/A |
| Q2 FY2021Period end 2021-06-30 | $239.80K | +29.13% | N/A |
| Q1 FY2021Period end 2021-03-31 | $185.71K | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
